Senior insider sale
KYMERA THERAPEUTICS, INC. — senior position signals high conviction
$189.91M
1.63M shares
What this filing means
BVF PARTNERS L P/IL plans to sell 1.63M shares of KYMERA THERAPEUTICS, INC. valued at approximately $189.91M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/26/2026ACC: 0000921895-26-001685
DirectorOther
Since Aug 2020
1.63M
Shares to sell
$189.91M
Approx. market value
1.63M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Acquired upon the automatic conversion of private shares in connection with the Issuer's initial public offering on August 21, 2020. The private shares were acquired and fully paid for on March 11, 2020.
N/A
8/21/2020
1.63MTotal acquired1.63M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/21/2020 | Acquired upon the automatic conversion of private shares in connection with the Issuer's initial public offering on August 21, 2020. The private shares were acquired and fully paid for on March 11, 2020. N/A | 1.63M | — |
| Total | 1.63M | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.63M
Market value
$189.91M
6/26/2026
Total
Units
1.63M
Value
$189.91M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/26/2026 | 1.63M | $189.91M | NASDAQ | Planned |
| Total | 1.63M | $189.91M | ||